Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • News (561)
  • Slides (197)
  • Podcasts (4)
  • Videos (2)
  • Interview
  • TCTMD Talking Points
  • Daily News
  • Conference News
  • Industry News
  • Editor's Corner
  • Features
  • Conversations in Cardiology
  • Fellow Talk
  • TCT (240)
  • EuroPCR (37)
  • ESC (24)
  • ACC (20)
  • CRT (7)
  • AHA (5)
  • TCT Abstracts Posters (5)
  • SCAI (4)
  • VIVA (4)
  • CIT (3)
  • TCTAP (2)
  • CX Symposium (1)
  • Fellows (1)
  • JIM (1)
  • TCT Mediterranean (1)
  • TCT Russia (1)
  • DES/BRS/DCB (456)
  • Coronary (302)
  • ACS/AMI (119)
  • Clinical Cardiology (64)
  • CAD Pharma (59)
  • Cath Lab (43)
  • Policy & Practice (38)
  • Cardiac Surgery (31)
  • Imaging & Physiology (28)
  • Diabetes (27)
  • Angiography/QCA (24)
  • Endovascular (19)
  • OCT (18)
  • IVUS/NIRS (16)
  • Popliteal/Infrapopliteal (15)
  • Structural Heart (14)
  • Clinical Pharma (13)
  • Aortic Valve (12)
  • Guidelines (10)
  • Women's Heart (10)
  • CTO (8)
  • Prevention (8)
  • Femoral (7)
  • Heart Failure (7)
  • Heart Rhythm (7)
  • Renovascular (7)
  • Approvals (5)
  • Plaque Modification (5)
  • Vascular Access/Closure (5)
  • Lipids (4)
  • PFO/ASD (4)
  • Quality (4)
  • Alerts (3)
  • Carotid (3)
  • Mitral Valve (3)
  • Training (3)
  • Atrial Fibrillation (2)
  • CT/CT-FFR (2)
  • FFR (2)
  • Heart Rhythm Pharma (2)
  • Hemodynamic Support (2)
  • Hypertension (2)
  • Left Atrial Appendage (2)
  • Public Health (2)
  • Aortic (1)
  • Congenital (1)
  • Echo (1)
  • Hemodynamics (1)
  • Iliac (1)
  • MRI (1)
  • Obesity (1)
  • Stroke (1)
  • Tricuspid Valve (1)
  • 2025 (6)
  • 2024 (9)
  • 2023 (14)
  • 2022 (5)
  • 2021 (14)
  • 2020 (17)
  • 2019 (35)
  • 2018 (32)
  • 2017 (44)
  • 2016 (584)
Displaying 541 - 560 of 764
Sort: Relevancy | Date
Randomized comparison of Biolimus-eluting (Nobori)  and Everolimus-eluting (Xience/Promus)  stents in patients with multivessel coronary artery disease: 12-month follow-up data...
Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet
January 31, 2013
Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study
Presentation TCT 2013

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Presenter: Shinji Inaba, Gary Mintz, Kyeong Yun, Tadayuki Yakushiji, Takehisa Shimizu, Giora Weisz, Martin Leon, Jeffrey Moses, Gregg Stone, Akiko Maehara
January 31, 2013
Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...
Presentation TCT 2013

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Presenter: Tomohisa Tada, Adnan Kastrati, Robert Byrne, Tibor Schuster, Rezarta Cuni, Lamin King, Salvatore Cassese, Michael Joner, Steffen Massberg, Albert Sch?mig, Julinda Mehilli
January 31, 2013
LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY
Presentation TCT 2013

LONG TERM OUTCOME OF PATIENTS WITH BIFURCATED LESIONS RANDOMIZED TO SIROLIMUS OR EVEROLIMUS ELUTING STENT: THE SEA-CORP BC STUDY

Presenter: Francesco Burzotta, Pan Manuel, Trani Carlo, Medina Alfonso, SU?REZ DE LEZO Jos?, Niccoli Giampaolo, Romero Miguel, Porto Italo, Mazuelos Francisco, Leone Antonio Maria, Martin Pedro, Valentina Coluccia, SU?REZ DE LEZO Javier, OJEDA Soledad, Crea Filippo
January 31, 2013
Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...
Presentation TCT 2013

Intimal Hyperplasia and Vascular Remodeling after Everolimus-eluting and Sirolimus-eluting Stent Implantation in Diabetic Patients. The Randomized Diabetes and Drug-Eluting Sten...

Presenter: Lisbeth Antonsen, Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Evald H?j Christiansen, Knud N?rregaard Hansen, Anne Kaltoft, Henrik Steen Hansen, Leif Thuesen, Jens Flensted Lassen
January 31, 2013
Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis
Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia
January 31, 2013
Cost Effectiveness Of Everolimus-Eluting Stents Compared To First Generation Drug-Eluting Stents In Contemporary Clinical Practice
Presentation TCT 2013

Cost Effectiveness Of Everolimus-Eluting Stents Compared To First Generation Drug-Eluting Stents In Contemporary Clinical Practice

Presenter: Robert Applegate, Matthew Sacrinty, Sanjay Gandhi, Michael Kutcher, Renato Santos, Timothy Smith, William Little
January 31, 2013
Cost Effectiveness Of Everolimus-Eluting Stents Compared To Propensity Score Matched Bare Metal Stents In Contemporary Clinical Practice
Presentation TCT 2013

Cost Effectiveness Of Everolimus-Eluting Stents Compared To Propensity Score Matched Bare Metal Stents In Contemporary Clinical Practice

Presenter: Robert Applegate, Matthew Sacrinty, Sanjay Gandhi, Michael Kutcher, Renato Santos, Timothy Smith, William Little
January 31, 2013
Comparison of Zotarolimus-Eluting stents versus Everolimus –Eluting stents versus Sirolimus-Eluting and in Patients with Long Coronary Artery Lesions Assessed by Volumetric...
Presentation TCT 2013

Comparison of Zotarolimus-Eluting stents versus Everolimus –Eluting stents versus Sirolimus-Eluting and in Patients with Long Coronary Artery Lesions Assessed by Volumetric...

Presenter: Young-Rak Cho, Jung-Min Ahn, Soo-Jin Kang, Young-Hak Kim, Won-Jang Kim, Jong-Young Lee, Woo Seok Lee, Gyung-Min Park, Seung-Jung Park
January 31, 2013
Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease
Presentation TCT 2013

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Presenter: Hironori Kitabata, Joshua Loh, Gabriel Sardi, Salem Badr, Danny Dvir, Israel Barbash, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman
January 31, 2013
Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry
Presentation TCT 2013

Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry

Presenter: Renato Valenti, Angela Migliorini, Guido Parodi, Ruben Vergara, Nazario Carrabba, Emilio Vincenzo Dovellini, David Antoniucci
January 31, 2013
Clinical Relevance of Endothelial Dysfunction after Everolimus-Eluting Stent Implantation Compared to First Generation Drug-Eluting Stent.
Presentation TCT 2013

Clinical Relevance of Endothelial Dysfunction after Everolimus-Eluting Stent Implantation Compared to First Generation Drug-Eluting Stent.

Presenter: Yoshifumi Nakajima, Kengo Tanabe, Jiro Aoki, Takuya Hashimoto, Kazuyuki Yahagi, Makoto Nakashima, Shuzou Tanimoto, Hiroyoshi Nakajima, Kazuhiro Hara
January 31, 2013
Clinical Outcomes with Everolimus-Eluting Stent for the Treatment of Cardiac Allograft Vasculopathy
Presentation TCT 2013

Clinical Outcomes with Everolimus-Eluting Stent for the Treatment of Cardiac Allograft Vasculopathy

Presenter: Babak Azarbal, Boris Arbit, Radhakrishnan Ramaraj, David Chang, Jignesh Patel, Jon Kobashigawa
January 31, 2013
Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES
Presentation TCT 2013

Clinical Outcome of Diabetic and Non-Diabetic Patients Treated With Second-Generation Zotarolimus-Eluting and Everolimus-Eluting DES

Presenter: Kenneth Tandjung, Hanim Sen, Mounir Basalus, K Gert van Houwelingen, Marije L?wik, Martin Stoel, Frits de Man, J. Hans Louwerenburg, Gerard Linssen, Mark Nienhuis, Rogier Nijhuis, Job van der Palen, Clemens von Birgelen
January 31, 2013
Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study
Presentation TCT 2013

Clinical Outcome in Chinese Patients with Long Lesion or Small Vessel / Multivessel Disease Receiving XIENCE V Everolimus-Eluting Stent: Early Results from the SEEDS Study

Presenter: Bo Xu, Yuejin Yang, Yaling Han, Bao Li, Qiang Liu, Guoying Zhu, Junyu Cui, Lang Li, Shuzheng Lu
January 31, 2013
Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine
Presentation TCT 2013

Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine

Presenter: Armando Tellez, Elina Donskoy, Natalia Sushkova, Paul Seifert, Taylor Palmieri, William Rate, Samantha Stone, Michael Eppihimer, Greg Kaluza, Barbara Huibregtse, Keith Dawkins, Juan Granada
January 31, 2013
A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients
Presentation TCT 2013

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

Presenter: Jean Fajadet, Eulogio Garcia, David Hildick-Smith, Sonia Petronio, Sigmund Silber, Franz-Josef Neumann, Azfar Zaman, Jochen W?hrle, Mark Spence, simon elhadad
January 31, 2013
News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn
Jason Kahn
January 22, 2013
News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn
Jason Kahn
January 22, 2013
News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn
Jason Kahn
January 02, 2013

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Current page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • …
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing